A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough
Public ClinicalTrials.gov record NCT02993822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of chronic refractory cough.
Study identification
- NCT ID
- NCT02993822
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 315 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2017 (Actual)
- Primary completion
- Jan 14, 2019 (Actual)
- Completion
- Jan 24, 2019 (Actual)
- Last update posted
- Apr 26, 2022
2017 – 2019
United States locations
- U.S. sites
- 46
- U.S. states
- 22
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site 15 | Chandler | Arizona | 85224 | — |
| Study Site 43 | Los Angeles | California | 90025 | — |
| Study Site 52 | Mission Viejo | California | 92692 | — |
| Study Site 20 | San Diego | California | 92108 | — |
| Study Site 28 | San Jose | California | 95117 | — |
| Study Site 25 | Centennial | Colorado | 80112 | — |
| Study Site 36 | Colorado Springs | Colorado | 80907 | — |
| Study Site 48 | Waterbury | Connecticut | 06708 | — |
| Study Site 68 | Clearwater | Florida | 33765 | — |
| Study Site 59 | Jacksonville | Florida | 32224 | — |
| Study Site 12 | Largo | Florida | 33778 | — |
| Study Site 62 | Miami | Florida | 33060 | — |
| Study Site 57 | Miami | Florida | 33186 | — |
| Study Site 33 | Tampa | Florida | 33613 | — |
| Study Site 11 | Winter Park | Florida | 32789 | — |
| Study Site 60 | Meridian | Idaho | 83642 | — |
| Study Site 39 | Normal | Illinois | 61761 | — |
| Study Site 34 | Baltimore | Maryland | 21236 | — |
| Study Site 42 | Edina | Minnesota | 55435 | — |
| Study Site 41 | Minneapolis | Minnesota | 55402 | — |
| Study Site 37 | Rochester | Minnesota | 55905 | — |
| Study Site 27 | Missoula | Montana | 59808 | — |
| Study Site 16 | Las Vegas | Nevada | 89128 | — |
| Study Site 32 | Rochester | New York | 14618 | — |
| Study Site 55 | Charlotte | North Carolina | 28204 | — |
| Study Site 24 | Charlotte | North Carolina | 28207 | — |
| Study Site 53 | Charlotte | North Carolina | 29732 | — |
| Study Site 50 | Gastonia | North Carolina | 28054 | — |
| Study Site 54 | Greensboro | North Carolina | 27403 | — |
| Study Site 73 | Mooresville | North Carolina | 28117 | — |
| Study Site 71 | Raleigh | North Carolina | 27612 | — |
| Study Site 56 | Cincinnati | Ohio | 45231 | — |
| Study Site 74 | Oklahoma City | Oklahoma | 73131 | — |
| Study Site 26 | Tulsa | Oklahoma | 74136 | — |
| Study Site 38 | East Providence | Rhode Island | 02914 | — |
| Study Site 21 | Charleston | South Carolina | 29420 | — |
| Study Site 72 | Charleston | South Carolina | 29464 | — |
| Study Site 22 | Dallas | Texas | 75231 | — |
| Study Site 35 | Dallas | Texas | 75231 | — |
| Study Site 10 | Houston | Texas | 77074 | — |
| Study Site 49 | San Antonio | Texas | 78229 | — |
| Study Site 23 | Waco | Texas | 76712 | — |
| Study Site 58 | Salt Lake City | Utah | 84108 | — |
| Study Site 19 | Charlottesville | Virginia | 22911 | — |
| Study Site 14 | Bellingham | Washington | 98225 | — |
| Study Site 13 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02993822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02993822 live on ClinicalTrials.gov.